A proteomic platform to identify off-target proteins associated with therapeutic modalities that induce protein degradation or gene silencing
Abstract Novel modalities such as PROTAC and RNAi have the ability to inadvertently alter the abundance of endogenous proteins. Currently available in vitro secondary pharmacology assays, which evaluate off-target binding or activity of small molecules, do not fully assess the off-target effects of...
Saved in:
Main Authors: | Xin Liu, Ye Zhang, Lucas D. Ward, Qinghong Yan, Tanggis Bohnuud, Rocio Hernandez, Socheata Lao, Jing Yuan, Fan Fan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/bceb4a3a9b72451bb8dd1f5b780cc4d7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APC/C-mediated degradation of dsRNA-binding protein 4 (DRB4) involved in RNA silencing.
by: Katia Marrocco, et al.
Published: (2012) -
Proximity labeling proteomics reveals critical regulators for inner nuclear membrane protein degradation in plants
by: Aobo Huang, et al.
Published: (2020) -
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
by: Qingdi Quentin Li, et al.
Published: (2017) -
Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins
by: Nhan H. Nguyen, et al.
Published: (2021) -
Off-the-shelf proximity biotinylation for interaction proteomics
by: Irene Santos-Barriopedro, et al.
Published: (2021)